Get 20% lifetime commission for referring investors to digrin.com
here.
Phathom Pharmaceuticals, Inc. ( PHAT) - Key Metrics
PHAT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.79 | -$0.29 | -$0.07 | -$0.07 |
| 2025Q3 | $0.67 | -$0.41 | -$0.19 | -$0.19 |
| 2025Q2 | $0.55 | -$1.05 | -$0.87 | -$0.87 |
| 2025Q1 | $0.40 | -$1.31 | -$1.18 | -$1.18 |
PHAT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -14.30 |
| 2025Q3 | ? | -7.21 |
| 2025Q2 | ? | -2.29 |
| 2025Q1 | ? | -1.20 |
PHAT
Price: $10.94
52 week price:
Earnings Per Share: -2.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 521200
Market Capitalization: 893.3 million